Benton B M, Zang J H, Thorner J
Department of Molecular and Cell Biology, University of California, Berkeley 94720-3202.
J Cell Biol. 1994 Nov;127(3):623-39. doi: 10.1083/jcb.127.3.623.
The gene (FPR3) encoding a novel type of peptidylpropyl-cis-trans-isomerase (PPIase) was isolated during a search for previously unidentified nuclear proteins in Saccharomyces cerevisiae. PPIases are thought to act in conjunction with protein chaperones because they accelerate the rate of conformational interconversions around proline residues in polypeptides. The FPR3 gene product (Fpr3) is 413 amino acids long. The 111 COOH-terminal residues of Fpr3 share greater than 40% amino acid identity with a particular class of PPIases, termed FK506-binding proteins (FKBPs) because they are the intracellular receptors for two immunosuppressive compounds, rapamycin and FK506. When expressed in and purified from Escherichia coli, both full-length Fpr3 and its isolated COOH-terminal domain exhibit readily detectable PPIase activity. Both fpr3 delta null mutants and cells expressing FPR3 from its own promoter on a multicopy plasmid have no discernible growth phenotype and do not display any alteration in sensitivity to the growth-inhibitory effects of either FK506 or rapamycin. In S. cerevisiae, the gene for a 112-residue cytosolic FKBP (FPR1) and the gene for a 135-residue ER-associated FKBP (FPR2) have been described before. Even fpr1 fpr2 fpr3 triple mutants are viable. However, in cells carrying an fpr1 delta mutation (which confers resistance to rapamycin), overexpression from the GAL1 promoter of the C-terminal domain of Fpr3, but not full-length Fpr3, restored sensitivity to rapamycin. Conversely, overproduction from the GAL1 promoter of full-length Fpr3, but not its COOH-terminal domain, is growth inhibitory in both normal cells and fpr1 delta mutants. In fpr1 delta cells, the toxic effect of Fpr3 overproduction can be reversed by rapamycin. Overproduction of the NH2-terminal domain of Fpr3 is also growth inhibitory in normal cells and fpr1 delta mutants, but this toxicity is not ameliorated in fpr1 delta cells by rapamycin. The NH2-terminal domain of Fpr3 contains long stretches of acidic residues alternating with blocks of basic residues, a structure that resembles sequences found in nucleolar proteins, including S. cerevisiae NSR1 and mammalian nucleolin. Indirect immunofluorescence with polyclonal antibodies raised against either the NH2- or the COOH-terminal segments of Fpr3 expressed in E. coli demonstrated that Fpr3 is located exclusively in the nucleolus.
在对酿酒酵母中先前未鉴定的核蛋白进行搜索的过程中,分离出了编码一种新型肽基脯氨酰顺反异构酶(PPIase)的基因(FPR3)。PPIase被认为与蛋白质伴侣协同作用,因为它们能加速多肽中脯氨酸残基周围构象相互转换的速率。FPR3基因产物(Fpr3)由413个氨基酸组成。Fpr3的111个COOH末端残基与一类特定的PPIase具有超过40%的氨基酸同一性,这类PPIase被称为FK506结合蛋白(FKBP),因为它们是两种免疫抑制化合物雷帕霉素和FK506的细胞内受体。当在大肠杆菌中表达并纯化时,全长Fpr3及其分离的COOH末端结构域都表现出易于检测到的PPIase活性。fpr3缺失突变体和在多拷贝质粒上从其自身启动子表达FPR3的细胞都没有明显的生长表型,并且对FK506或雷帕霉素的生长抑制作用的敏感性没有任何改变。在酿酒酵母中,之前已经描述了一种112个残基的胞质FKBP(FPR1)的基因和一种135个残基的内质网相关FKBP(FPR2)的基因。即使是fpr1 fpr2 fpr3三突变体也是有活力的。然而,在携带fpr1缺失突变(赋予对雷帕霉素抗性)的细胞中,从GAL1启动子过表达Fpr3的C末端结构域,而不是全长Fpr3,恢复了对雷帕霉素的敏感性。相反,从GAL1启动子过表达全长Fpr3,而不是其COOH末端结构域,在正常细胞和fpr1缺失突变体中都具有生长抑制作用。在fpr1缺失细胞中,Fpr3过表达的毒性作用可以被雷帕霉素逆转。Fpr3的NH2末端结构域的过表达在正常细胞和fpr1缺失突变体中也具有生长抑制作用,但这种毒性在fpr1缺失细胞中不能被雷帕霉素改善。Fpr3的NH2末端结构域包含长段的酸性残基与碱性残基块交替出现,这种结构类似于在核仁蛋白中发现的序列,包括酿酒酵母NSR1和哺乳动物核仁素。用针对在大肠杆菌中表达的Fpr3的NH2或COOH末端片段产生的多克隆抗体进行间接免疫荧光显示,Fpr3仅位于核仁中。